Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
1.340
0.00 (0.00%)
At close: Aug 24, 2026, 4:00 PM EDT
1.350
+0.010 (0.75%)
After-hours: Aug 24, 2026, 7:34 PM EDT

Sonoma Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
6443512
Market Cap Growth
-23.29%4.17%36.33%-42.82%-63.48%-19.48%
Enterprise Value
22-2125
Last Close Price
1.342.132.193.3319.5380.20

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-11.9311.9311.9311.9311.93
PS Ratio
0.290.190.250.200.340.98
PB Ratio
0.971.190.800.420.571.43
P/TBV Ratio
0.971.190.800.420.571.43
PEG Ratio
-0.890.890.890.890.89

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
0.080.09-0.050.180.41

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.110.270.070.100.110.16
Net Debt / Equity Ratio
-0.70-0.50-1.15-0.41-0.37-0.69
Net Debt / EBITDA Ratio
3.620.671.420.560.671.06
Net Debt / FCF Ratio
1.730.3830.171.050.461.38
Asset Turnover
1.341.411.000.820.760.75
Inventory Turnover
3.533.693.132.873.193.33
Quick Ratio
1.561.041.911.691.781.72
Current Ratio
2.992.503.093.373.712.82
Return on Equity (ROE)
-42.52%-84.60%-65.55%-68.51%-61.79%-72.35%
Return on Assets (ROA)
-5.37%-11.12%-16.31%-18.97%-16.29%-21.75%
Return on Capital Employed (ROCE)
-11.10%-27.00%-38.70%-42.70%-36.50%-45.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-35.28%-86.13%-97.70%-186.28%-113.48%-40.92%
FCF Yield
-41.38%-111.90%-4.75%-92.47%-141.46%-35.28%
Buyback Yield / Dilution
-55.39%-35.70%-172.75%-168.12%-27.93%-32.92%
SEC Filings: 10-K · 10-Q